In contrast, the tumor suppressor role of TGFβ signaling is underscored by presence of inactivating TGFβ receptor mutations in many different cancers, including colorectal and pancreatic cancer [77,97,98,99] (Figure 3). Here, TGFB1 is linked to neoplasm.